COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,946 Articles (22,604 medRxiv, 8,342 bioRxiv)

Most recent first Previous |  Page 1157: Articles 11561-11570  | Next

One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the vaccine in civil circulation in Moscow
Dolzhikova, I., Gushchin, V., Shcheblyakov, D., Tsybin, A., Shchetinin, A., Pochtovyi, A., Komissarov, A., Kleymenov, D., Kuznetsova, N., Tukhvatulin, A., Zubkova, O., Dzharullaeva, A., Kovyrshina, A., Lubenets, N., Grousova, D., Erokhova, A., Izhaeva, F., Popova, O., Ozharovskaya, T., Semikhin, A., Tokarskaya, E., Shmarov, M., Nikitenko, N., Shidlovskaya, E. V., Bykonia, E., Mazunina, E., Divisenko, E., Vasilchenko, L., Popova, L., Danilenko, D., Lioznov, D., Tkachuk, A., Borisevich, S., Naroditsky, B., Logunov, D., Gintsburg, A.
10.1101/2021.10.08.21264715 — Posted: 2021-10-14 Discussion: Onsite
A molecular surveillance-guided vector control response to concurrent dengue and West Nile virus outbreaks in a COVID-19 hotspot of Florida
Coatsworth, H., Lippi, C., Vasquez, C., Ayers, J. B., Stephenson, C. J., Waits, C., Florez, M., Wilke, A. B. B., Unlu, I., Medina, J., Alcaide, M. L., Ryan, S. J., Lednicky, J. A., Beier, J. C., Petrie, W., Dinglasan, R. R.
10.1101/2021.10.08.21264776 — Posted: 2021-10-13
The R346K Mutation in the Mu Variant of SARS-CoV-2 Alter the Interactions with Monoclonal Antibodies from Class 2: A Free Energy of Perturbation Study
Fratev, F.
10.1101/2021.10.12.463781 — Posted: 2021-10-13
SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy
Ryu, J. K., Sozmen, E. G., Dixit, K., Montano, M., Matsui, Y., Liu, Y., Helmy, E., Deerinck, T. J., Yan, Z., Schuck, R., Acevedo, R. M., Spencer, C. M., Thomas, R., Pico, A. R., Zamvil, S. S., Lynch, K. L., Ellisman, M. H., Greene, W. C., Akassoglou, K.
10.1101/2021.10.12.464152 — Posted: 2021-10-13
Low antigen abundance limits efficient T-cell recognition of highly conserved regions of SARS-CoV-2
Swaminathan, S., Lineburg, K., Ambalathingal, G., Crooks, P., Grant, E., Mohan, S., Raju, J., Panikkar, A., Le Texier, L., Tong, Z., Chew, K., Neller, M., Gowda, H., Short, K., Gras, S., Smith, C., Khanna, R.
10.1101/2021.10.13.464181 — Posted: 2021-10-13
AUG-3387, a Human-Derived Monoclonal Antibody Neutralizes SARS-CoV-2 Variants and Reduces Viral Load from Therapeutic Treatment of Hamsters In Vivo
Emig, C. J., Mena, M. A., Henry, S. J., Vitug, A., Ventura, C. J., Fox, D., Nguyenla, X. H., Xu, H., Moon, C., Sahakijjpijarn, S., Kuehl, P. J., Revelli, D., Cui, Z., Williams, R. O., Christensen, D. J.
10.1101/2021.10.12.464150 — Posted: 2021-10-13
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Greaney, A. J., Starr, T. N., Eguia, R. T., Loes, A. N., Khan, K., Karim, F., Cele, S., Bowen, J. E., Logue, J. K., Corti, D., Veesler, D., Chu, H. Y., Sigal, A., Bloom, J. D.
10.1101/2021.10.12.464114 — Posted: 2021-10-13
Genetically determined serum testosterone level and Covid-19 illness level: A mendelian randomization study
Xiong, J., Ma, Z., Miao, R., Huang, J., Kong, X.-J., Qu, Y., Yang, X.
10.1101/2021.10.10.21264779 — Posted: 2021-10-13
Heterologous SARS-CoV-2 Booster Vaccinations: Preliminary Report
Atmar, R. L., Lyke, K. E., Deming, M. E., Jackson, L. A., Branche, A. R., El Sahly, H. M., Rostad, C. A., Martin, J. M., Johnston, C., Rupp, R. E., Mulligan, M. J., Brady, R. C., Frenck, R. W., Backer, M., Kottkamp, A. C., Babu, T. M., Rajakumar, K., Edupuganti, S., Falsey, A. R., Posavad, C. M., Archer, J. I., Crandon, S., Nayak, S. U., Szydlo, D., Zemanek, J., Dominguez Islas, C. P., Brown, E. R., Suthar, M. S., McElrath, M. J., McDermott, A. B., O'Connell, S. E., Montefiori, D. C., Eaton, A., Neuzil, K. M., Stephens, D. S., Roberts, P. C., Beigel, J.
10.1101/2021.10.10.21264827 — Posted: 2021-10-13 Discussion: Onsite
An objective systematic comparison of the most common adverse events of COVID-19 vaccines
Behrens, C., Gasperazzo, T., Samii-Moghadam, M., Lampe, J. B.
10.1101/2021.10.11.21264830 — Posted: 2021-10-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).